We recently reported that when myoblasts fuse, m-calpain could be exte
riorized. Indeed, at present a number of works support this hypothesis
because this enzyme was localized intercellularly and more particular
ly associated to extracellular matrix components. Knowing that the cel
l surface of the fusing myoblast is supposed to undergo many changes,
we addressed the question whether m-calpain could be involved in the p
henomenon of fusion via fibronectin cleavage or degradation. Using dif
ferent digestion experiments, we demonstrated that soluble purified fi
bronectin and highly insoluble fibronectin fibrils represent very good
substrates for this proteinase; moreover, at the burst of fusion, fib
ronectin proteolytic fragments could be identified. On the other hand,
we have conducted biological assays on cultured myoblasts using a def
ined medium supplemented by exogenous factors capable of stimulating o
r inhibiting m-calpain activity. The effects of such factors on rat my
oblast fusion and concomitantly on the targeted glycoprotein were anal
yzed and quantified. When m-calpain activity and the phenomenon of fus
ion were reduced (defined medium without insulin), the amount of the 2
20-kDa fibronectin band was increased by 43%. When m-calpain activity
and myoblast fusion were prevented by addition of antibodies to m-calp
ain or calpain inhibitor II, the fibronectin concentration was higher
since it was increased by similar to 67 and similar to 71%, respective
ly. In addition, when observed at the ultrastructural level, m-calpain
seems to be localized at the potential fusion site of myoblasts and m
ore particularly associated to the extracellular matrix when muscle ce
lls were initially treated by anti-m-calpain IgG. Taken together, thes
e results support the hypothesis that exteriorized m-calpain could be,
in part, involved in myoblast fusion via fibronectin alteration or de
gradation. (C) 1997 Academic Press.